Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)

Historical Holders from Q1 2019 to Q1 2025

Symbol
INMB on Nasdaq
CUSIP
45782T105
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
23M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
6.17M
Holdings value
$28.8M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
71
Number of buys
44
Number of sells
-14
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Praetorian PR LLC 7.2% +28.3% $13.3M $3.36M 1.66M +33.8% Kupperman Harris Mar 31, 2025

Institutional Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 70.6K $551K +$42.2K $7.81 7
2024 Q4 6.17M $28.8M +$2.16M $4.67 71
2024 Q3 5.35M $28.8M +$6.02M $5.39 66
2024 Q2 4.57M $40.3M +$15.4M $8.82 56
2024 Q1 2.74M $32.2M +$4.84M $11.75 50
2023 Q4 2.23M $25.2M +$1.92M $11.26 45
2023 Q3 2.06M $14M +$742K $6.77 34
2023 Q2 2M $18.2M +$1.89M $9.08 30
2023 Q1 1.8M $11.6M +$1.1M $6.46 30
2022 Q4 1.65M $10.4M -$729K $6.34 31
2022 Q3 1.91M $11.9M -$743K $6.20 30
2022 Q2 2M $17.5M -$2.2M $8.83 32
2022 Q1 2.28M $19.2M -$2.11M $8.42 30
2021 Q4 2.47M $25.2M +$4.97M $10.20 40
2021 Q3 1.91M $37.1M +$3.98M $19.42 38
2021 Q2 1.73M $30.4M +$8.49M $17.57 38
2021 Q1 1.31M $15.5M +$5.45M $11.88 31
2020 Q4 792K $13.6M +$1.19M $17.20 23
2020 Q3 992K $10.2M +$6.46M $10.30 26
2020 Q2 359K $1.88M +$107K $5.17 11
2020 Q1 341K $1.14M +$199K $3.33 8
2019 Q4 282K $1.64M +$40.4K $5.80 9
2019 Q3 275K $1.62M +$1.39M $5.90 9
2019 Q2 35.7K $346K -$68.2K $9.85 6
2019 Q1 44.7K $350K +$350K $7.83 3